Rapid and Quantitative Detection of Human Antibodies Against the 2019 Novel Coronavirus SARS CoV2 and its Variants as a Result of Vaccination and Infection

Benjamin Taubner, Ruben Peredo-Wende, Ananthakrishnan Ramani, Gurpreet Singh, Klemen Strle, Nathaniel C. Cady
doi: https://doi.org/10.1101/2021.07.13.21260442

Article Information

doi 
https://doi.org/10.1101/2021.07.13.21260442
History 
  • July 16, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Benjamin Taubner1,
  2. Ruben Peredo-Wende2,
  3. Ananthakrishnan Ramani3,
  4. Gurpreet Singh4,
  5. Klemen Strle5 and
  6. Nathaniel C. Cady1,*
  1. 1College of Nanoscale Science & Engineering, SUNY Polytechnic Institute, Albany, NY, USA
  2. 2Division of Rheumatology Albany Medical Center, Albany, NY, 12208
  3. 3Division of Infectious Diseases Albany Medical Center, Albany, NY 12208
  4. 4Internal Medicine Albany Medical Center, Albany, NY 12208
  5. 5Wadsworth Center, New York State Department of Health, Albany, NY, USA and School of Public Health, University at Albany, Albany, NY, USA
  1. ↵*Corresponding Author: Nathaniel C. Cady, PhD, SUNY Polytechnic Institute, ncady{at}sunypoly.edu
Back to top
Posted July 16, 2021.
Download PDF
Data/Code
Email
Rapid and Quantitative Detection of Human Antibodies Against the 2019 Novel Coronavirus SARS CoV2 and its Variants as a Result of Vaccination and Infection
Benjamin Taubner, Ruben Peredo-Wende, Ananthakrishnan Ramani, Gurpreet Singh, Klemen Strle, Nathaniel C. Cady
medRxiv 2021.07.13.21260442; doi: https://doi.org/10.1101/2021.07.13.21260442
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area